✦ LIBER ✦

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

✍ Scribed by Kyung Hee Lee; Min Kyoung Kim; Yeol Hong Kim; Baek Yeol Ryoo; Ho Yeong Lim; Hong Suk Song; Hoon Kyo Kim; Myung Ah Lee; Seock Ah Im; Heung Moon Chang; Jae Yong Cho; Dae Young Zang; Bong Seog Kim; Jun Suk Kim

Publisher: Springer
Year: 2008
Tongue: English
Weight: 341 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0873-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

A phase I study of imexon plus gemcitabi

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

✍ Steven J. Cohen; Mark M. Zalupski; Manuel R. Modiano; Paul Conkling; Yehuda Z. P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 275 KB

A phase II study of gemcitabine in combi

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer

✍ Hyun Jung Kim; Nam Su Lee; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Young G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 347 KB

Docetaxel plus gemcitabine in combinatio

Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study

✍ N. Xenidis; L. Chelis; K. Amarantidis; E. Chamalidou; P. Dimopoulos; N. Courcout 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 288 KB

Phase II study of biweekly docetaxel and

Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer

✍ Chikara Kunisaki; Masazumi Takahashi; Hirochika Makino; Takashi Oshima; Shoichi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 272 KB

A multiple-center phase II study of week

A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer

✍ Jen-Shi Chen; Yen-Yang Chen; Jen-Sheng Huang; Kun-Yun Yeh; Ping-Tsung Chen; Wen- 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 181 KB